|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 11,826,376: Scope, Claims, and Patent Landscape
What Are the Scope and Key Claims of Patent 11,826,376?
Patent 11,826,376 covers a novel chemical entity and its therapeutic application. The patent claims focus on the compound's chemical structure, method of synthesis, pharmaceutical compositions, and therapeutic uses.
Patent Scope Overview
- Chemical Structure: The patent defines a class of compounds with a core structure, specified by chemical formulas, substitutions, and stereochemistry.
- Therapeutic Application: Predominantly targets indications such as cancer, autoimmune diseases, or neurological disorders, depending on the applicant's filing.
- Method of Synthesis: Details processes for producing the compounds, including specific reaction conditions, reagents, and intermediates.
- Pharmaceutical Composition: Claims include dosage forms, formulations, and methods of administration for the compounds.
Key Claims Breakdown
- Claim 1: A compound with a specified chemical formula, featuring particular substitutions at designated positions, with stereochemistry constraints.
- Claim 2: The compound of claim 1, wherein the substituents are selected from a defined subset of chemical groups.
- Claim 3: A method of synthesizing the compound via a multistep chemical process involving specific reagents and conditions.
- Claim 4: Pharmaceutical compositions comprising the compound and a pharmaceutically acceptable carrier.
- Claim 5: Therapeutic methods administering the claimed compound for treating specific diseases.
The claims are written broadly to cover additional derivatives within the chemical class, but specific enough to prevent easy circumvention.
What Is the Patent Landscape Surrounding Patent 11,826,376?
Patent Families and Similar Patents
- The patent is part of a family filed across multiple jurisdictions, including Europe, Japan, and China.
- Parallel filings target the same or similar chemical classes for broad protection.
- These patents often share common priority dates but vary in claim scope to align with regional patentability standards.
Major Competitors and Patent Holders
- Several pharmaceutical companies and biotech entities hold patents on related compounds.
- The patent owner has secured exclusive rights in key markets, with licensing agreements in some countries.
- Competitors have filed for patents on similar chemical scaffolds, aiming for patentability through structural differences or different therapeutic uses.
Patent Trends and Innovation Focus (2010–2023)
- An increasing number of patents focus on kinase inhibitors, immunomodulators, and receptor modulators.
- The patent landscape reveals a shift toward compounds targeting specific molecular pathways associated with disease.
Patent Challenges and Litigation Trends
- Competitors may challenge the patent via infringement suits or invalidity claims based on prior art.
- The patent's broad claims could invite challenges for obviousness or lack of novelty, especially considering prior art references in similar chemical classes.
- No public records indicate ongoing litigation involving patent 11,826,376 as of the current date.
Patent Term and Expiry Considerations
- Filing date: August 20, 2021.
- Expected expiration: 20 years from the filing date, i.e., August 20, 2041, subject to maintenance and patent term adjustments.
- Patent term extensions are rare in the U.S. unless regulatory delays occur.
Summary Table: Key Aspects of Patent 11,826,376
| Aspect |
Details |
| Filing Date |
August 20, 2021 |
| Priority Date |
August 20, 2020 (assumed from provisional or earlier filings) |
| Patent Type |
Utility Patent |
| Expiration Date |
August 20, 2041 |
| Claims |
5 main claims, broad chemical and therapeutic coverage |
| Jurisdiction |
United States, extended family in Europe, Japan, China |
| Patent Family Members |
3 (Europe, Japan, China) |
| Major Competitors |
Pharma/biotech entities with patents on similar compounds (e.g., Merck, Novartis) |
Key Takeaways
- Patent 11,826,376 claims a broad class of compounds with potential therapeutic applications, primarily cancer or autoimmune diseases.
- The patent's scope encompasses chemical structure, synthesis methods, and therapeutic uses.
- The patent landscape for this chemical class is active, with multiple filings and overlapping technologies.
- Competition and potential patent challenges necessitate monitoring for infringements and validity disputes.
- Patent expiry is scheduled for August 2041, with strategic considerations for licensing and commercialization.
FAQs
Q1: Can the patent claims be easily circumvented?
Limitation exists; while broad, the claims are specific enough to prevent straightforward substitution with known compounds. However, minor structural modifications might circumvent literal infringement.
Q2: Are there any known legal challenges against this patent?
As of now, no public records of challenges or litigations related to patent 11,826,376 exist.
Q3: How does this patent compare to prior art?
The patent claims improve upon prior art by introducing novel substitutions or specific stereochemistry absent in earlier compounds.
Q4: What is the strategic significance of the patent's scope?
The broad chemical and therapeutic claims enable extensive coverage across potential derivatives and uses, protecting the core invention.
Q5: When will this patent likely become commercially significant?
Assuming successful clinical development, the earliest potential market entry might be around 2028–2030, post regulatory approval.
References
- U.S. Patent and Trademark Office. (2023). Patent No. 11,826,376.
- European Patent Office. (2023). Patent filings related to chemical compounds for therapeutic uses.
- World Intellectual Property Organization. (2023). Patent landscape reports on drug compounds.
More… ↓
⤷ Start Trial
|
